Author Information
Tatjana Pekmezović is a distinguished researcher affiliated with the Institute of Epidemiology, Faculty of Medicine, in Belgrade, Serbia. Her primary research focus is on neurology and epidemiology, with a particular interest in multiple sclerosis, neuromyelitis optica spectrum disorders, and other neurological conditions. Her expertise extends to the epidemiological study of infectious diseases, as evident from her recent work related to COVID-19.Research Contributions
Tatjana Pekmezović has made significant contributions to the field of epidemiology and neurology. Her research has explored a variety of topics, including the impact of immunosuppressive treatment on the humoral response to SARS-CoV-2 infection and vaccines in patients with neuromyelitis optica spectrum disorders, the link between impaired fibrinolysis and digital vasculopathy in systemic sclerosis, and factors affecting the outcome in the treatment of glioblastoma. She has also examined the burden and healthcare use of patients with migraine and tension-type headache in post-conflict areas, and has investigated complications such as late-onset neutropenia associated with Ocrelizumab in multiple sclerosis patients. Additionally, her work includes the development of resources like the Multiple Sclerosis Data Alliance Catalogue for the discovery of metadata from real-world multiple sclerosis data sources.Aliases
Tatjana Pekmezović is known by several aliases, including Tatjana Pekmezovic, Tatjana Pekmezović, T. Pekmezovic, and Tatjana P Pekmezovic. These variations are often found in her publications and citations.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
550 |
| H-index |
11 |
| Paper Count |
50 |
